488 related articles for article (PubMed ID: 16456688)
41. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
Van Poznak C; Estilo C
Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
[TBL] [Abstract][Full Text] [Related]
42. [Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].
Capsoni F
Reumatismo; 2008; 60(1):6-13. PubMed ID: 18432320
[TBL] [Abstract][Full Text] [Related]
43. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
Lee J
J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.
Lo JC; O'Ryan FS; Gordon NP; Yang J; Hui RL; Martin D; Hutchinson M; Lathon PV; Sanchez G; Silver P; Chandra M; McCloskey CA; Staffa JA; Willy M; Selby JV; Go AS;
J Oral Maxillofac Surg; 2010 Feb; 68(2):243-53. PubMed ID: 19772941
[TBL] [Abstract][Full Text] [Related]
45. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
Lobato JV; Maurício AC; Rodrigues JM; Cavaleiro MV; Cortez PP; Xavier L; Botelho C; Hussain NS; Santos JD
J Plast Reconstr Aesthet Surg; 2008; 61(1):99-106. PubMed ID: 18068658
[TBL] [Abstract][Full Text] [Related]
46. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
Cetiner S; Sucak GT; Kahraman SA; Aki SZ; Kocakahyaoglu B; Gultekin SE; Cetiner M; Haznedar R
J Bone Miner Metab; 2009; 27(4):435-43. PubMed ID: 19240969
[TBL] [Abstract][Full Text] [Related]
47. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw.
Kang HS; Lee JW; Kim JS
Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007
[TBL] [Abstract][Full Text] [Related]
48. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis.
Ortega C; Montemurro F; Faggiuolo R; Vormola R; Nanni D; Goia F; Gilardino MO; Aglietta M
Acta Oncol; 2007; 46(5):664-8. PubMed ID: 17562443
[TBL] [Abstract][Full Text] [Related]
49. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
Melo MD; Obeid G
J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
[TBL] [Abstract][Full Text] [Related]
50. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
52. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
53. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.
Rachner TD; Platzbecker U; Felsenberg D; Hofbauer LC
Mayo Clin Proc; 2013 Apr; 88(4):418-9. PubMed ID: 23541016
[TBL] [Abstract][Full Text] [Related]
54. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.
Wessel JH; Dodson TB; Zavras AI
J Oral Maxillofac Surg; 2008 Apr; 66(4):625-31. PubMed ID: 18355585
[TBL] [Abstract][Full Text] [Related]
55. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
Udvardy E; Redl P; Márton I
Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.
Walter C; Grötz KA; Kunkel M; Al-Nawas B
Support Care Cancer; 2007 Feb; 15(2):197-202. PubMed ID: 16941133
[TBL] [Abstract][Full Text] [Related]
57. [Jaw osteonecrosis induced by oral biphosphonates: 12 cases].
Barrier A; Lescaille G; Rigolet A; Descroix V; Goudot P; Ruhin B
Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):196-202. PubMed ID: 20810140
[TBL] [Abstract][Full Text] [Related]
58. Bisphosphonate-related osteonecrosis of the jaw: an overview.
Ruggiero SL
Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
[TBL] [Abstract][Full Text] [Related]
59. Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case series.
Kumar SK; Meru M; Sedghizadeh PP
J Contemp Dent Pract; 2008 Jan; 9(1):63-9. PubMed ID: 18176650
[TBL] [Abstract][Full Text] [Related]
60. Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab.
Ngamphaiboon N; Frustino JL; Kossoff EB; Sullivan MA; O'Connor TL
Clin Breast Cancer; 2011 Aug; 11(4):252-7. PubMed ID: 21729657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
